Anset 8

Presentation: Each tablet contains 8 mg of Ondansetron. 

Indications: Anset 8 is indicated for the prevention of nausea and vomiting associated with:

• Chemotherapy-induced nausea and vomiting (CINV)
• Radiotherapy-induced nausea and vomiting (RINV)
• Postoperative ¹ nausea and vomiting (PONV) 

Dosage and Administration:

• Dosage should be determined by the treating physician based on the specific indication and the patient's condition.
• Chemotherapy-Induced Nausea and Vomiting:
  • Adults: The usual dose is 8 mg administered orally 1-2 hours before chemotherapy, followed by 8 mg every 12 hours for 1-2 days after chemotherapy.
  • Children (4-11 years): The usual dose is 4 mg administered orally 30 minutes before chemotherapy, followed by 4 mg every 8 hours for 1-2 days after chemotherapy.
• Radiotherapy-Induced Nausea and Vomiting:
  • Adults: The usual dose is 8 mg administered orally 1-2 hours before radiotherapy.
• Postoperative Nausea and Vomiting:
  • Adults: The usual dose is 16 mg administered orally one hour before anesthesia, or 8 mg administered orally shortly before anesthesia followed by two 8 mg doses at eight-hour intervals.
  • Children (over 2 years): The usual dose is 0.1 mg/kg body weight (up to a maximum of 4 mg) administered orally shortly before anesthesia, followed by one or two subsequent doses.

Anset 8 tablets can be taken with or without food.

Side Effects: Common side effects may include:

• Headache
• Constipation
• Diarrhea
• Fatigue
• Dizziness
• Drowsiness

Less common side effects may include:

• Fever
• Dry mouth
• Abdominal pain
• Transient elevations in liver enzymes
• In rare cases, serious allergic reactions or heart rhythm problems may occur.

Precautions:

• Inform your doctor if you are allergic to ondansetron or other similar medications (e.g., granisetron, palonosetron).
• Use with caution in patients with liver problems or a history of heart rhythm disorders.
• Ondansetron may mask progressive ileus and/or gastric distension in postoperative patients.
• The safety of Anset 8 during pregnancy has not been fully established. It should only be used if clearly needed and the potential benefit outweighs the risk to the fetus. Consult your doctor before use.
• Ondansetron passes into breast milk. Caution should be exercised when Anset 8 is administered to a breastfeeding woman.

Storage: Store below 30°C, protected from light and moisture. Keep out of the reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication, including the appropriate dosage and timing for your condition. They can assess your individual medical condition and provide the most appropriate advice.